Artemether and Clindamycin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 1, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Artemether
No brand names on recordClindamycin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed artemether (a malaria medicine) along with clindamycin (an antibiotic). The concern here is mostly on paper, not something proven in patients. In theory, artemether may speed up how your body breaks down clindamycin. If that happens, there could be a little less clindamycin working in your body, which could make the antibiotic slightly less effective.
The good news is this is easy to stay on top of. Keep taking both exactly as prescribed, and let your pharmacist or doctor know you're on them together. Your care team can watch how well your infection is clearing and adjust things if needed.
Effect: Theoretical reduction in clindamycin (a CYP3A4 substrate) exposure with possible reduced antibacterial efficacy.
Mechanism: Proposed CYP3A4 induction by artemether/lumefantrine, increasing clearance of the CYP3A4 substrate. Direction is loss of substrate exposure (lower AUC/Cmax), not accumulation. Neither agent's activity depends on prodrug activation here.
- Severity: Moderate
- Onset: Unspecified
- Evidence: Theoretical only
Management: Exercise caution with coadministration. No fixed dose adjustment is defined; monitor clinical/therapeutic response of clindamycin and individualize therapy. Consider closer follow-up of infection resolution.
What happens
Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate
Interaction Deep Dive
Use care if artemether/lumefantrine is given together with CYP3A4 substrates, because such combined use can lower the exposure of these substrates and thereby diminish their effectiveness1.
Why it happens (mechanism)
Induction of CYP3A4-substrate metabolism by artemether/lumefantrine
How to manage this interaction
This interaction is theoretical, so there's no cause for alarm. The main practical point is making sure your antibiotic keeps doing its job.
- Keep taking both medicines as prescribed unless your doctor tells you otherwise.
- Tell your pharmacist and prescriber you're using them together so they're aware.
- Your care team may monitor you more closely to confirm your infection is clearing as expected, and can tailor treatment if needed.
- Report any worsening or lingering signs of infection (fever, more redness, no improvement).
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Artemether and Clindamycin together?
This is a theoretical interaction where artemether might slightly lower clindamycin levels and make the antibiotic a bit less effective; keep taking both as prescribed and let your care team monitor that your infection is clearing. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Artemether and Clindamycin interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Artemether and Clindamycin interaction managed?
This interaction is theoretical, so there's no cause for alarm. The main practical point is making sure your antibiotic keeps doing its job. Keep taking both medicines as prescribed unless your doctor tells you otherwise. Tell your pharmacist and prescriber you're using them together so they're aware. Your care team may monitor you more closely to confirm your infection is clearing as expected, an… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Artemether or Clindamycin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Keep reading about Artemether
Keep reading about Clindamycin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist